José de Jesús Vidal-Mayo

José de Jesús Vidal-Mayo

Auto-generated profile, based on publicly available information

José de Jesús Vidal-Mayo

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2020 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
Javier Mancilla-GalindoJavier Mancilla-Galindo
Javier Mancilla-Galindo
JVJ. M. Vera-Zertuche
J. M. Vera-Zertuche
Addí Navarro-CruzAddí Navarro-Cruz
Addí Navarro-Cruz
OBOrieta Segura Badilla
Orieta Segura Badilla
GRG. Reyes-Velázquez
G. Reyes-Velázquez
Ashuin Kammar-GarcíaAshuin Kammar-García
Ashuin Kammar-García
Most of the existing prediction models for COVID-19 lack validation, are inadequately reported or are at high risk of bias, a reason which has led to discourage their use. Few existing models have the potential to be extensively used by healthcare providers in low-resource settings since many require laboratory and imaging predictors. Therefore, we sought to develop and validate a multivariable prediction model of death in Mexican patients with COVID-19, by using demographic and patient history predictors. We conducted a national retrospective cohort study in two different sets of patients from the Mexican COVID-19 Epidemiologic Surveillance Study. Patients with a positive reverse transcription-polymerase chain reaction for SARS-CoV-2 and complete unduplicated data were eligible. In total, 83 779 patients were included to develop the scoring system through a multivariable Cox regression model; 100 000, to validate the model. Eight predictors (age, sex, diabetes, chronic obstructive pulmonary disease, immunosuppression, hypertension, obesity and chronic kidney disease) were included in the scoring system called PH-Covid19 (range of values: −2 to 25 points). The predictive model has a discrimination of death of 0.8 (95% confidence interval (CI) 0.796–0.804). The PH-Covid19 scoring system was developed and validated in Mexican patients to aid clinicians to stratify patients with COVID-19 at risk of fatal outcomes, allowing for better and efficient use of resources.

1 January 2022 in Journal of the Academy of Consultation-Liaison Psychiatry
Verified
Journal Article
Open access
MGMiguel García-Grimshaw
Miguel García-Grimshaw
ECErwin Chiquete
Erwin Chiquete
AJAmado Jiménez-Ruiz
Amado Jiménez-Ruiz
JVJosé de Jesús Vidal-Mayo
José de Jesús Vidal-Mayo
SGSamara Lissete Grajeda-González
Samara Lissete Grajeda-González
FFFernando Daniel Flores-Silva
Fernando Daniel Flores-Silva
The coronavirus disease 2019 (COVID-19) pandemic dramatically increased the number of patients requiring treatment in an intensive care unit (ICU) or invasive mechanical ventilation (IMV) worldwide. Delirium is a well-known neuropsychiatric complication of patients with acute respiratory diseases, representing the most frequent clinical expression of acute brain dysfunction in critically ill patients, especially in those undergoing IMV. Among hospitalized COVID-19 patients, delirium incidence ranges from 11–80%, depending on the studied population and hospital setting. To determine risk factors for the development of delirium in hospitalized patients with COVID-19 pneumonia. We retrospectively studied consecutive hospitalized adult (≥18 years) patients with confirmed COVID-19 pneumonia from March 15 to July 15, 2020, in a tertiary-care hospital in Mexico City. Delirium was assessed by the attending physician or trained nurse, with either the Confusion Assessment Method (CAM) for the intensive care unit or the CAM brief version, according to the appropriate diagnostic tool for each hospital setting. Consultation-liaison psychiatrists and neurologists confirmed all diagnoses. We calculated adjusted hazard ratios (aHR) with 95% confidence interval (CI) using a Cox proportional-hazards regression model. We studied 1,017 (64.2% men; median age 54 years, interquartile range 44–64), of whom 166 (16.3%) developed delirium (hyperactive in 75.3%); 78.9% of our delirium cases were detected in patients under IMV. The median of days from admission to diagnosis was 14 (IQR 8–21) days. Unadjusted mortality rates between delirium and no delirium groups were similar (23.3% vs. 24.1; risk ratio 0.962, 95% CI 0.70–1.33). Age (aHR 1.02, 95% CI 1.01–1.04; P=0.006), an initial neutrophil-to-lymphocyte ratio ≥9 (aHR 1.81, 95% CI 1.23–2.65; P=0.003), and requirement of IMV (aHR 3.39, 95% CI 1.47–7.84; P=0.004) were independent risk factors for in-hospital delirium development. Delirium is a common in-hospital complication of patients with COVID-19 pneumonia, associated with disease severity; given the extensive number of active COVID-19 cases worldwide, it is essential to detect patients who are most likely to develop delirium during hospitalization. Improving its preventive measures may reduce the risk of the long-term cognitive and functional sequelae associated with this neuropsychiatric complication.

20 September 2022 in Archivos de Neurociencias
Verified
Journal Article
Open access
PDF file
JVJosé de Jesús Vidal-Mayo
José de Jesús Vidal-Mayo
URUriel Guzmán Ramírez
Uriel Guzmán Ramírez
THThierry Hernandez-Gilsoul
Thierry Hernandez-Gilsoul
Ashuin Kammar-GarcíaAshuin Kammar-García
Ashuin Kammar-García
AMAyari Pérez Méndez
Ayari Pérez Méndez
Javier Mancilla-GalindoJavier Mancilla-Galindo
Javier Mancilla-Galindo
Antecedentes. El estado epiléptico (EE) es una emergencia médica caracterizada por actividad epiléptica continua o recurrente con una alta mortalidad. La escala STESS (Status Epilepticus Severity Score) permite evaluar el pronóstico de pacientes con EE. Objetivo. Describir las características clínicas de los pacientes con EE en nuestro centro, determinar las variables asociadas a mortalidad y determinar la capacidad predictora de la escala STESS para mortalidad intrahospitalaria. Material y métodos. Estudio de cohorte retrospectivo. Se incluyeron pacientes con diagnóstico de EE durante el periodo de 2000-2020. Se aplicó la escala pronóstica STESS a todos los pacientes. Se obtuvieron datos de las características clínicas y mortalidad intrahospitalaria. Se aplicó un análisis de regresión de Cox para determinar el riesgo de mortalidad por cada punto de la escala STESS, y se calculó el área bajo la curva ROC para determinar la capacidad de discriminación de la escala. Resultados. Fueron incluidos 60 pacientes. La presentación clínica predominante fue el EE convulsivo generalizado en 51.7%, las etiologías más frecuentes fueron sintomáticas agudas (46.7%). La mortalidad hospitalaria fue 40%. El riesgo de mortalidad se incrementa un 38% por cada punto de STESS (B=0.38, HR=1.48, IC95%:1.13-1.94, p=0.005). El área bajo la curva ROC de la escala STESS fue 0.72 con un punto de corte óptimo ≥3 puntos para discriminación de mortalidad hospitalaria. Conclusiones. La escala STESS se asocia significativamente con la mortalidad intrahospitalaria y puede ser usada como predictor de los desenlaces adversos en pacientes con EE.

29 April 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JRJuan José Rodríguez-Crespo
Juan José Rodríguez-Crespo
EGEduardo Gutiérrez-León
Eduardo Gutiérrez-León
PDPedro Dammann-Beltrán
Pedro Dammann-Beltrán
JSJurhiat Alejandro Seaman-Gómez
Jurhiat Alejandro Seaman-Gómez
SCSergio Contreras-Garduño
Sergio Contreras-Garduño
JSJosé Sifuentes-Osornio
José Sifuentes-Osornio
Background: Lack of adherence to international recommendations leads to worse outcomes. During the COVID-19 pandemic, the total number and proportion of hospitalized patients increased, consequently straining hospital care and hindering adherence. Aims: To evaluate adherence to clinical guidelines at our center, before, during, and shortly after the COVID-19 pandemic-induced hospital strain, and its association with clinical outcomes, using a random, balanced retrospective cohort. Design: A balanced and randomized sample of 50 patients per year between 2019 and 2022 was drawn from electronic medical records and analyzed with multivariable and logistic regression models. The primary outcome was a composite of in-hospital death, hemodynamic decompensation within the first 7 days, and in-hospital bleeding. Results: The global non-adherence in our study was 45.4%. The main risk factors for non-adherence were any mortality risk classification above low-risk PE and a PESI class different from class I, with ORs of 3.47 (95% CI 2.07–5.82) and 1.57 (95% CI 1.04–2.37), respectively. In both periods (COVID-19 season and non-COVID-19 season), non-adherent management strongly correlated with the composite outcome, OR = 2.36 (95% CI, 1.23–4.54). Non-adherence was also associated with worse in-hospital outcomes, with an incidence rate of the composite outcome of 21.08 per 1000 days/person (95% CI 10.97–40.51) and 47.7 per 1000 days/person (95% CI 33.39–67.50), and an attributable risk of 1.09% (95% CI −8.47%−10.64%). Conclusions: Overall, our findings highlight the need to prioritize human and material resources to ensure adherence to the standards of care for PE patients.

8 September 2020 in medRxiv
Verified
Preprint
Open access
PDF file
Javier Mancilla-GalindoJavier Mancilla-Galindo
Javier Mancilla-Galindo
JVJuan Mauricio Vera-Zertuche
Juan Mauricio Vera-Zertuche
Addí Navarro-CruzAddí Navarro-Cruz
Addí Navarro-Cruz
OBOrieta Segura Badilla
Orieta Segura Badilla
GRG. Reyes-Velázquez
G. Reyes-Velázquez
Ashuin Kammar-GarcíaAshuin Kammar-García
Ashuin Kammar-García
Summary: We sought to develop and validate a multivariable prediction model of death in Mexican patients with COVID-19, by using demographic and patient history predictors. We conducted a national retrospective cohort in two different sets of patients from the Mexican COVID-19 Epidemiologic Surveillance Study. To develop the model, we included 264,026 patients tested for SARS-CoV-2 between February 28 and May 30, 2020. To validate the model, 592,160 patients studied between June 1 and July 23, 2020 were included. Patients with a positive RT-PCR for SARS-CoV-2 and complete unduplicated data were eligible. Demographic and patient history variables were analyzed through Multivariable Cox regression models to evaluate predictors to be included in the prognostic scoring system called PH-Covid19. 83,779 patients were included to develop the model; 100,000, to validate the model. Eight predictors (age, sex, diabetes, COPD, immunosuppression, hypertension, obesity, and CKD) were included in the PH-Covid19 scoring system (range of values: −2 to 25 points). The predictive model has a discrimination of death of 0.8 (95%CI:0.796-0.804). The PH-Covid19 scoring system was developed and validated in Mexican patients to aid clinicians to stratify patients with COVID-19 at risk of fatal outcomes, allowing for better and efficient use of resources.